Should I Buy MKSI? MKSI 2026 Analysis

Should You Buy MKS Incorporated (MKSI) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Buy

Latest Price

242.960

1 Day change

7.11%

52 Week Range

246.350

Analysis Updated At

2026/02/05

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Buy now: MKSI is in a confirmed uptrend (bullish moving-average stack) with multiple near-term fundamental tailwinds (debt refinancing + improving semi/WFE cycle) and strong, recent analyst target raises.
Intellectia Proprietary Trading Signals
- AI Stock Picker: no signal on given stock today.
- SwingMax: No signal on given stock recently.
What I expect next (impatient-buyer friendly): near-term chop is possible (MACD weakening + elevated IV into earnings), but the broader setup favors upside continuation toward $242–$250 if the stock holds above support.
Key line in the sand: a break and hold below $216.7 (S1) would invalidate the cleanest bullish setup; otherwise dips are buyable.

Technical Analysis

Trend: Bullish overall — SMA_5 > SMA_20 > SMA_200 signals a sustained uptrend.
Momentum: Short-term momentum is cooling — MACD histogram -1.005 and negatively expanding (often precedes consolidation/pullback even within an uptrend).
RSI (6): 54.37 (neutral) — not overbought; still room for continuation if buyers defend support.
Key levels:
- Pivot: 229.463 (price ~228.99, essentially at pivot)
- Resistance: 242.237 (R1) then 250.129 (R2)
- Support: 216.689 (S1) then 208.797 (S2)
Pattern-based odds (given): ~70% chance of a modest gain (+1.52% next day, +0.93% next week, +0.5% next month) — bullish bias but not a “straight-line” move.
Market tape: S&P 500 down -0.97% while MKSI is up +3.58% regular session — relative strength is supportive.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Positioning/sentiment: Put/call ratios below 1 on both OI and volume are net bullish (calls outweigh puts).
Activity: Today’s option volume 1057 vs 30-day avg is elevated (176.76%) — rising attention/sentiment.
Volatility: 30D IV 69.67 vs HV 46.49 and IV percentile 93.63 — options are pricing in large moves (often earnings-related); sentiment is bullish but priced richly.
Interpretation: Options market leans bullish, but elevated IV implies the stock can swing sharply around upcoming catalysts.

Technical Summary

Sell

Buy

Positive Catalysts

- Debt/refinancing catalyst (news-driven): Closed €1B senior notes and refinanced $2.2B loans, extending maturities and reducing interest expense — supports EPS and de-risks balance sheet.
- Analyst-driven momentum: Multiple firms raised targets sharply in January, reinforcing the bull narrative.
- Cycle tailwind: Commentary across notes points to a more constructive 2026–2027 WFE environment and AI-led complexity benefiting exposure.
- Upcoming earnings: QDEC 2025 earnings on 2026-02-17 (AH) with Street EPS est 2.51 — potential upside catalyst if guidance confirms acceleration.

Neutral/Negative Catalysts

- Near-term technical risk: MACD deterioration + price sitting at pivot means a quick dip toward $216–$209 is plausible if momentum fades.
- Event risk/volatility: Very high IV into earnings suggests the market expects a big move; any guide-down or margin commentary could be punished.
- Margin trend: Most recent snapshot shows gross margin down YoY, which can cap upside if it persists.
- No supportive flow signals from insiders/hedge funds: both reported as neutral, so there’s no “smart money” confirmation in the provided data.

Financial Performance

Latest reported quarter: 2025/Q3
- Revenue: $988M, +10.27% YoY (solid top-line re-acceleration)
- Net income: $74M, +19.35% YoY (profit growing faster than sales)
- EPS: 1.09, +18.48% YoY
- Gross margin: 40.28%, down 2.73% YoY (watch this—growth is good, but margin compression is the key blemish)
Read-through: Growth is healthy and improving; the main fundamental watch item is whether margins stabilize as demand improves.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent trend: Clearly positive — a series of price target raises and reiterated Buys/Outperforms/Overweights through Jan 2026 following improved outlook/guidance tone.
Notable upgrades/raises:
- Deutsche Bank: PT to $265 from $180, Buy (more constructive 2026/27 WFE)
- Needham: PT to $260 from $210, Buy (optimism for 2026/27)
- Mizuho: PT to $260 from $215, Outperform (WFE acceleration)
- BofA: PT to $255 from $215, Buy (AI-led drivers)
- KeyBanc: PT to $250 from $180, Overweight (valuation still attractive; debt noted)
- TD Cowen: PT to $230 from $200, Buy (benefit from extending maturities/lower interest)
Wall Street pros: improving semi equipment cycle + AI/packaging complexity + refinancing lowering interest burden.
Wall Street cons: debt still a recurring discussion point historically, and execution/margins remain the swing factor.

11 Analyst Rating

Wall Street analysts forecast MKSI stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for MKSI is 190.7 USD with a low forecast of 170 USD and a high forecast of 215 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

11 Buy

0 Hold

0 Sell

Strong Buy

Current: 226.830

Low

170

Averages

190.7

High

215

Current: 226.830

Low

170

Averages

190.7

High

215

Mizuho

Outperform

maintain

$215 -> $260

AI Analysis

2026-01-28

Reason

Mizuho

Price Target

$215 -> $260

AI Analysis

2026-01-28

maintain

Outperform

Reason

Mizuho raised the firm's price target on MKS Inc. to $260 from $215 and keeps an Outperform rating on the shares. The firm estimates 2026 wafer fab equipment spending will be up 13% year-over-year in 2026 and 12% in 2027. This is a "significant acceleration" versus Mizuho's prior expectations, the analyst notes.

Needham

Buy

maintain

$210 -> $260

2026-01-22

Reason

Needham

Price Target

$210 -> $260

2026-01-22

maintain

Buy

Reason

Needham raised the firm's price target on MKS Inc. to $260 from $210 and keeps a Buy rating on the shares. The company's modest upside Q4 pre-announcement yesterday shouldn't come as a shock to investors who have been tracking the positive tone coming out of the semi and PCB - Printed Circuit Board -markets in recent months, and the firm is also increasingly optimistic about MKS' growth prosects in 2026 and 2027, the analyst tells investors in a research note.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for MKSI

Unlock Now

MKSI Should I Buy

MKSI Should I Buy

Should You Buy MKS Incorporated (MKSI) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch